Fedenia Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Buy
+115
New +$118K 0.03% 151
2026
Q1
Sell
-305
Closed -$328K 132
2025
Q4
$328K Sell
305
-37
-11% -$35.4K 0.13% 120
2025
Q3
$261K Buy
+342
New +$255K 0.1% 139
2025
Q2
Sell
-338
Closed -$279K 146
2025
Q1
$279K Buy
338
+212
+168% +$176K 0.18% 93
2024
Q4
$97.3K Buy
+126
New +$104K 0.06% 212

Other funds holding LLY

Fedenia Advisers's LLY Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Eli Lilly (LLY) in Q2 2026: 115 shares worth $138K. The stake represents 0.03% of the portfolio and ranks #151 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in LLY as recently as Q4 2025.

Fedenia Advisers first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $328K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fedenia Advisers held 115 shares of Eli Lilly worth $138K as of Q2 2026.
  • Eli Lilly was a new Fedenia Advisers position in Q2 2026.
  • Eli Lilly made up 0.03% of Fedenia Advisers's portfolio in Q2 2026, its #151 holding.
  • Fedenia Advisers first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Fedenia Advisers's Eli Lilly position peaked at $328K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.